Cargando…
The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
BACKGROUND: Catheter infections remain one of the most persistent adverse events causing significant morbidity, economic impact and mortality. Several strategies have been proposed to reduce these infections including the use of catheters embedded with antibiotics and/or antiseptics. One reoccurring...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210168/ https://www.ncbi.nlm.nih.gov/pubmed/34222960 http://dx.doi.org/10.1093/jacamr/dlaa002 |
_version_ | 1783709257499148288 |
---|---|
author | Reitzel, Ruth A Rosenblatt, Joel Gerges, Bahgat Z Jarjour, Andrew Fernández-Cruz, Ana Raad, Issam I |
author_facet | Reitzel, Ruth A Rosenblatt, Joel Gerges, Bahgat Z Jarjour, Andrew Fernández-Cruz, Ana Raad, Issam I |
author_sort | Reitzel, Ruth A |
collection | PubMed |
description | BACKGROUND: Catheter infections remain one of the most persistent adverse events causing significant morbidity, economic impact and mortality. Several strategies have been proposed to reduce these infections including the use of catheters embedded with antibiotics and/or antiseptics. One reoccurring challenge is the fear that antimicrobial medical devices will induce resistance. The aim of this systematic review is to evaluate the evidence for induced antimicrobial resistance caused by exposure to antimicrobial medical devices. METHODS: Four electronic databases [MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus] were screened for studies published between 1983 and 2019 regarding assessment of microbial resistance with use of medical devices containing chlorhexidine, minocycline, rifampicin or combinations thereof. Development of new resistance, selection for tolerant organisms and ‘no change in resistance’ were assessed. RESULTS: Forty-four publications, grouped by study type and stratified by drug assessed, were included for analyses. The majority of studies found no change in resistance after exposure to antimicrobial medical devices (13 in vitro, 2 in vivo, 20 clinical). Development of new resistance was commonly reported with the use of rifampicin as a single agent and only reported in one study assessing the minocycline/rifampicin combination (M/R); however, the increase in MIC was well below clinical relevance. CONCLUSIONS: Emergence of new resistance to combinations of M/R, minocycline/rifampicin/chlorhexidine (M/R/CH) and chlorhexidine/silver sulfadiazine (CHXSS) was rare. No clinical trials confirmed its occurrence and some refuted it. The risk of development of new resistance to these antimicrobial combinations appears more fear-based than substantiated by clinical and experimental evidence but warrants continued surveillance. |
format | Online Article Text |
id | pubmed-8210168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-82101682021-07-02 The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review Reitzel, Ruth A Rosenblatt, Joel Gerges, Bahgat Z Jarjour, Andrew Fernández-Cruz, Ana Raad, Issam I JAC Antimicrob Resist Systematic Review BACKGROUND: Catheter infections remain one of the most persistent adverse events causing significant morbidity, economic impact and mortality. Several strategies have been proposed to reduce these infections including the use of catheters embedded with antibiotics and/or antiseptics. One reoccurring challenge is the fear that antimicrobial medical devices will induce resistance. The aim of this systematic review is to evaluate the evidence for induced antimicrobial resistance caused by exposure to antimicrobial medical devices. METHODS: Four electronic databases [MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus] were screened for studies published between 1983 and 2019 regarding assessment of microbial resistance with use of medical devices containing chlorhexidine, minocycline, rifampicin or combinations thereof. Development of new resistance, selection for tolerant organisms and ‘no change in resistance’ were assessed. RESULTS: Forty-four publications, grouped by study type and stratified by drug assessed, were included for analyses. The majority of studies found no change in resistance after exposure to antimicrobial medical devices (13 in vitro, 2 in vivo, 20 clinical). Development of new resistance was commonly reported with the use of rifampicin as a single agent and only reported in one study assessing the minocycline/rifampicin combination (M/R); however, the increase in MIC was well below clinical relevance. CONCLUSIONS: Emergence of new resistance to combinations of M/R, minocycline/rifampicin/chlorhexidine (M/R/CH) and chlorhexidine/silver sulfadiazine (CHXSS) was rare. No clinical trials confirmed its occurrence and some refuted it. The risk of development of new resistance to these antimicrobial combinations appears more fear-based than substantiated by clinical and experimental evidence but warrants continued surveillance. Oxford University Press 2020-02-21 /pmc/articles/PMC8210168/ /pubmed/34222960 http://dx.doi.org/10.1093/jacamr/dlaa002 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Systematic Review Reitzel, Ruth A Rosenblatt, Joel Gerges, Bahgat Z Jarjour, Andrew Fernández-Cruz, Ana Raad, Issam I The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review |
title | The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review |
title_full | The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review |
title_fullStr | The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review |
title_full_unstemmed | The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review |
title_short | The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review |
title_sort | potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210168/ https://www.ncbi.nlm.nih.gov/pubmed/34222960 http://dx.doi.org/10.1093/jacamr/dlaa002 |
work_keys_str_mv | AT reitzelrutha thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT rosenblattjoel thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT gergesbahgatz thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT jarjourandrew thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT fernandezcruzana thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT raadissami thepotentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT reitzelrutha potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT rosenblattjoel potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT gergesbahgatz potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT jarjourandrew potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT fernandezcruzana potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview AT raadissami potentialfordevelopingnewantimicrobialresistancefromtheuseofmedicaldevicescontainingchlorhexidineminocyclinerifampicinandtheircombinationsasystematicreview |